Steven A. Pergam, MD, MPH

Associate Professor
Fred Hutchinson Cancer Research Center

Disclosure(s): Cidara: Participate in company sponsored clinical trial; F2G: Participate in company sponsored clinical trial; Global Life Technologies: Grant/Research Support; Symbio: Participate in company sponsored clinical trial

Poster(s):

• (P-25) Evaluating the Immunogenicity and Safety of Either Two High-Dose or Two Standard-Dose Influenza Vaccines Over Two Consecutive Seasons in Adult Hematopoietic Cell Transplant Recipients
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT